For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220818:nRSR4623Wa&default-theme=true
RNS Number : 4623W IP Group PLC 18 August 2022
FOR RELEASE ON 18 August 2022
IP Group plc
Scrip Dividend Reference Price
Further to the release of the Company's Half-Yearly Results on 03 August 2022,
the Company announces that the Scrip Reference Share Price for the 2022
interim dividend, payable on 19 September 2022, is 80.5 pence. Defined terms
in this announcement are as defined in the Scrip Dividend Terms and Conditions
which are available on the Company's website at
https://www.ipgroupplc.com/investor-relations/shareholder-information/scripdividend.
The Scrip Reference Share Price is the price at which the Company's Ordinary
Shares will be issued to shareholders who have elected to receive dividends in
the form of newly issued, fully paid shares in the Company in lieu of cash
through participation in the optional Scrip Dividend Scheme.
The Scrip Reference Share Price is the average of the mid closing price of the
Company's Ordinary Shares, as derived from the London Stock Exchange Daily
Official List, for the five dealing days commencing on the relevant
ex-dividend date (being 11, 12, 15, 16 and 17 August 2022).
Any shareholder entitled to the 2022 interim dividend who has not already
completed a Scrip Dividend Mandate Form or a Dividend Election Input Message
in CREST and is intending to do so, should refer to the Scrip Dividend Scheme
Terms and Conditions.
The final time and date for receipt of Scrip Dividend Mandates and Dividend
Election Input Messages in CREST is 5:00pm on 26 August 2022.
For more information, please contact:
IP Group plc www.ipgroupplc.com (http://www.ipgroupplc.com)
David Baynes, Chief Financial and Operating Officer +44 (0) 20 7444 0050
Liz Vaughan-Adams, Communications
+44 (0) 20 7444 0062/+44 (0) 7967 312125
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across life
sciences, technology and cleantech (through Kiko Ventures). The Group has a
strong track record of success, having been the founder investor in a number
of high-profile companies including Oxford Nanopore Technologies plc, and has
one of the most exciting portfolios of high-growth businesses in Europe. The
Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs
world-changing technologies emerging from the UK's leading universities and
research institutions. IP Group is listed on the Main Market of the London
Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DIVBKFBBFBKKBFD